Source: MarketScreener

AbbVie: London Stock Exchange : Form 8.3 - Replacement of ABBVIE INC.

(marketscreener.com) Regulatory Story Go to market news section ...https://www.marketscreener.com/news/London-Stock-Exchange-Form-8-3-Replacement-of-ABBVIE-INC--29971154/?utm_medium=RSS&utm_content=20200210

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from AbbVie's latest SEC filings

Annual Revenue

Based on data from AbbVie's latest SEC filings

Employees

Richard A. Gonzalez's photo - Chairman & CEO of AbbVie

Chairman & CEO

Richard A. Gonzalez

CEO Approval Rating

73/100

AbbVie discovers, develops and markets both biopharmaceuticals and small molecule drugs.

AbbVie's headquarters is located...
Read more